The conference will enable delegates to understand the fundamental principles of biotechnology, gain guidance on Biosimilars,
improve understanding of the key techniques used by biotechnologists, understand the importance of meeting regulatory requirements, learn about the key advances being made in regulatory requirements, understand how to identify potential patents – how and why they must be protected, and will include an introduction to biotechnology and molecular biology, biosimilars, development of production organisms, process optimisation and scale-up, product recovery and purification, patents in the biotechnology sector, analysis of Biopharmaceuticals, formulation design of Biopharmaceuticals, regulatory considerations and applications, process economics and will address future developments.
Speakers: Dr Adekunle Onadipe Pfizer Inc USA, Dr Adrian Haines Lonza Biologics plc, Dr Mark Richardson Biotech Regulatory Affairs Consultant UK, Kate Smith BioReliance UK, Alison Sykes Lonza Biologics plc UK, Dr Philip Webber Dehns Patent and Trademark Attorneys UK, Dr Robert J. Young Lonza Biologics plc UK
+44 1483 730071